Mehr zum Buch
The Encyclopedia of Heart Diseases is an accurate and reliable source of in-depth information on the diseases that kill more than 12 million individuals worldwide each year. Cardiovascular diseases are more prevalent than the combined incidence of all forms of cancer, diabetes, asthma, and leukemia. This encyclopedia thoroughly covers these ailments and includes in-depth analysis of less common and rare heart conditions. Researchers, clinicians, and students will find this resource an invaluable tool for quick reference before approaching the primary literature. Coverage includes more than 200 topics, including applied pharmacology of current and experimental cardiac drugs, gene therapy, MRI, electron-beam CT, PET scan, cardiac tests costs and justification, and new frontiers in cardiovascular research.
Buchkauf
Encyclopedia of Heart Diseases, M. I. Gabriel Khan
- Sprache
- Erscheinungsdatum
- 2010
- product-detail.submit-box.info.binding
- (Hardcover)
Keiner hat bisher bewertet.
- Titel
- Encyclopedia of Heart Diseases
- Sprache
- Englisch
- Autor*innen
- M. I. Gabriel Khan
- Erscheinungsdatum
- 2010
- Einband
- Hardcover
- Seitenzahl
- 922
- ISBN10
- 1607612186
- ISBN13
- 9781607612186
- Reihe
- Schlagwörter
- Sachbücher, Medizin & Gesundheit, Medizin
- Beschreibung
- The Encyclopedia of Heart Diseases is an accurate and reliable source of in-depth information on the diseases that kill more than 12 million individuals worldwide each year. Cardiovascular diseases are more prevalent than the combined incidence of all forms of cancer, diabetes, asthma, and leukemia. This encyclopedia thoroughly covers these ailments and includes in-depth analysis of less common and rare heart conditions. Researchers, clinicians, and students will find this resource an invaluable tool for quick reference before approaching the primary literature. Coverage includes more than 200 topics, including applied pharmacology of current and experimental cardiac drugs, gene therapy, MRI, electron-beam CT, PET scan, cardiac tests costs and justification, and new frontiers in cardiovascular research.